MichaelLLunnDO

Allergy & Immunology • Lone Tree, CO

Physician

Join to view full profile

Dr. Lunn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lunn's full profile

Already have an account?

Office
10240 Park Meadows Dr
Suite 410
Lone Tree, CO 80124
Phone+1 207-774-9839
Is this information wrong?

Education & Training

Penn State Milton S Hershey Medical CenterFellowship, Allergy and Immunology, 2009 - 2011
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine/Pediatrics, 2005 - 2009
Philadelphia College of Osteopathic MedicineClass of 2005

Certifications & Licensure

CA State License 2023 - 2025
CO State License 2016 - 2023
ME State License Active through 2016
PA State License 2005 - 2012
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2013

Clinical Trials

C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation Start of enrollment: 2010 Jul 01
Withdrawn
Phase 4

Publications & Presentations

PubMed

43 citations
Rhinitis and sleep
Michael Lunn, Timothy J. Craig> ;Sleep Medicine Reviews. 2011 Oct 1
15 citations
Hypersensitivity to Total Parenteral Nutrition Fat-Emulsion Component in an Egg-Allergic Child
Michael Lunn, Tracy Fausnight> ;Pediatrics. 2011 Oct 1
14 citations
Ecallantide for the treatment of hereditary angiodema in adults.
Michael Lunn, Erin Banta> ;Clinical Medicine Insights. Cardiology. 2011 May 17
19 citations
Cinryze™ as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety
Michael Lunn, Carah B. Santos, Timothy J. Craig> ;Journal of Blood Medicine. 2010 Aug 24
60 citations
Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients
Michael Lunn, Carah B. Santos, Timothy J. Craig> ;Annals of Allergy, Asthma & Immunology. 2010 Mar 1
Join now to see all

Press Mentions

Second IVIG Course Not Helpful in Poor-Prognosis Guillain-Barré SyndromeMarch 24th, 2021
No Association Between COVID-19 and Guillain-Barré Syndrome, Study FindsDecember 14th, 2020
Frequent Central Nervous System, Pachymeningeal and Plexus MRI Changes in POEMS SyndromeFebruary 12th, 2019